Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piboserod proof-of-biological-efficacy study in chronic congestive heart failure
2005-004487-22Phase 2Completed
- Sponsor
- Bio-Medisinsk Innovasjon AS
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of piboserod in heart failure (HF), sponsored by Bio-Medisinsk Innovasjon AS. Primary endpoint: Change in left ventricular ejection fraction. Started Dec 2005; status: completed.
02
Drugs
piboserod
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2005-004487-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004487-22.